EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

The Efficacy of Hemoperfusion in Severe COVID-19 Patients: A Systematic Review and Meta-Analysis

Song Shang, Bin Zhang, Baofa Wu, Yaping Dou, Lihai Zhang, Wuzhuang Sun, Wuzhuang Sun

Blood Purification · 14.05.2025 · 54 (7) · 384-403

DOI: 10.1159/000546256 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Blood Purification, online erschienen am 14.05.2025. Verfasst von Song Shang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, China, 18832855005@163.com. Hauptthemen laut MEDLINE: COVID-19, Hemoperfusion, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study aimed to conduct a meta-analysis and systematic review to assess the efficacy of hemoperfusion (HP) in patients with severe coronavirus disease 2019 (COVID-19).

Methods

A comprehensive search for candidate publications was performed using PubMed, Cochrane Library, and Embase. Studies investigating the effect of HP on mortality among severe COVID-19 patients were selected, including randomized controlled trials (RCTs), non-RCTs, and observational studies with control groups. The primary endpoint was the longest reported mortality, while the secondary endpoints were the length of stay, intensive care unit (ICU) stay, P/F ratio, and C-reactive protein (CRP). The Cochrane test (Q) and I2 test were used to quantify heterogeneity among the studies. The fixed-effect model (Mantel-Haenszel method) would be selected when there is no heterogeneity (p > 0.10 and I2 0.05; I2 = 68.2%). The results of the subgroup analysis of HP with HA series indicated a reduction in the mortality of patients with COVID-19 (RR 0.60 [0.46, 0.78]; p < 0.0001; I2 = 0.0%). The HP group had a longer hospital stay compared with the control group (weighted mean difference; WMD 5.25 [2.53, 7.97] days; p < 0.05; I2 = 28.0%), but not the ICU stay (ES 1.33 [−2.86, 5.53] days; p = 0.53; I2 = 85.5%). After HP, the P/F ratio (WMD 95.79 [74.46, 117.12] mm Hg; p < 0.05; I2 = 5.8%) increased, while CRP (WMD −44.03 [−68.97, −19.09] mg/L; p < 0.05; I2 = 86.9%) decreased.

Conclusion

This study found that HP did not significantly reduce mortality in COVID-19 patients; however, the HA series showed potential mortality benefits, suggesting its clinical applicability. While the HP group had longer hospital stays, ICU stay durations did not differ significantly. Notably, HP improved the P/F ratio and reduced CRP levels post-treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HemoperfusionSARS-CoV-2HumansLength of StayIntensive Care UnitsTreatment OutcomeC-Reactive Protein

Stichwörter der Autor:innen

COVID-19HemoperfusionLength of stayMeta-analysisMortality

Substanzen

C-Reactive Protein

Autor:innen und Institutionen

  • Department of Respiratory Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, China, 18832855005@163.com.
  • Department of Emergency, The First Hospital of Hebei Medical University, Shijiazhuang, China.
  • Department of Respiratory Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, China.

Zitieren

APA

Shang, S., Zhang, B., Wu, B., Dou, Y., Zhang, L., Sun, W., & Sun, W. (2025). The Efficacy of Hemoperfusion in Severe COVID-19 Patients: A Systematic Review and Meta-Analysis. Blood Purification, 54(7), 384-403. https://doi.org/10.1159/000546256

Vancouver

Shang S, Zhang B, Wu B, Dou Y, Zhang L, Sun W, et al. The Efficacy of Hemoperfusion in Severe COVID-19 Patients: A Systematic Review and Meta-Analysis. Blood Purification. 2025;54(7):384-403. doi:10.1159/000546256

BibTeX
@article{Shang2025,
  author = {Shang, Song and Zhang, Bin and Wu, Baofa and Dou, Yaping and Zhang, Lihai and Sun, Wuzhuang and Sun, Wuzhuang},
  title = {The Efficacy of Hemoperfusion in Severe COVID-19 Patients: A Systematic Review and Meta-Analysis},
  journal = {Blood Purification},
  year = {2025},
  volume = {54},
  number = {7},
  pages = {384--403},
  doi = {10.1159/000546256}
}
Kostenlos starten →